Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section
- 1 January 2001
- journal article
- case report
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 86 (1) , 135-138
- https://doi.org/10.1093/bja/86.1.135
Abstract
We describe a case of a 26 yr old primigravida at 39 weeks' gestation, with a diagnosis of peripartum cardiomyopathy, requiring urgent Caesarean section. The patient presented in severe heart failure and active labour. A general anaesthetic, using a target-controlled infusion of propofol and an intravenous infusion of remifentanil, was used to provide stable anaesthesia and analgesia for a successful delivery. The unusual diagnosis of peripartum cardiomyopathy and the potential benefits of the use of remifentanil in high-risk obstetric surgery are discussed.Keywords
This publication has 15 references indexed in Scilit:
- The use of remifentanil in general anaesthesia for Caesarean section in a patient with mitral valve diseaseAnaesthesia, 1998
- A1064 REMIFENTANIL PHARMACOKINETICS IN NEONATESAnesthesiology, 1997
- Peripartum cardiomyopathy: An ominous diagnosisAmerican Journal of Obstetrics and Gynecology, 1997
- The pharmacokinetics of remifentanilJournal of Clinical Anesthesia, 1996
- Peripartum cardiomyopathyAmerican Heart Journal, 1995
- Postpartum cardiomyopathy associated with maternal cocaine abuseThe American Journal of Cardiology, 1992
- A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian AfricaInternational Journal of Cardiology, 1992
- Peripartum CardiomyopathyNew England Journal of Medicine, 1985
- Peripartum Cardiomyopathy Due to MyocarditisNew England Journal of Medicine, 1982
- Complete Heart Block Complicating Cardiac CatheterizationChest, 1972